Inflammation-related markers such as absolute white blood cell count, C-reactive protein (CRP), cytokines, platelet-to-lymphocyte ratio (PLR), and NLR have been shown to be associated with specific outcomes in cancer patients [35]. This evidence concerns the gene CRP and cancer.